The Ozempic MDL, MDL 3094 In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation , names Novo Nordisk and Eli Lilly as defendants
When FDA investigators informed the firm that process validation had not been conducted prior to product distribution (which is a foundational cGMP requirement under 21 CFR 211.100), the company responded that it had been unaware of the legal obligation because its AI agent had never flagged it as a requirement
Disclosures Jos Luis Grriz has served as consultant to Boehringer Ingelheim, Mundipharma, AstraZeneca, and Novo Nordisk and has received speaker honoraria from Boehringer Ingelheim, Mundipharma, AstraZeneca, Novo Nordisk, Novartis, and Eli Lilly and Company
Tophi reduce the growth and viability of bone cells (osteoblasts) 24 and if left untreated, tophaceous gout can lead to significant joint erosion and loss of function
Certain side effects of semaglutide can disrupt your sleep
Keep snacks simple: Greek yogurt with berries, apple slices with nut butter, or a protein shake
